Nyotran liposomal formulation of nystatin data

ARNX announced interim results from a Phase II/III trial. In 33

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE